El Servei d'Hematologia de l'Hospital Universitari Son Espases ha presentat diferents comunicacions al 41st Annual Meeting of the European Society for Blood and Marrow Transplantation, celebrat a Istanbul, del 22 al 25 de març de 2015.
Leyre Bento, hematòloga de l'Hospital Universitari Son Espases, ha participat, junt amb l'Hospital General Universitari Gregorio Marañón, l'Hospital Regional Universitari de Màlaga, l'Hospital General Universitari Morales Meseguer, el Complex Assistencial de Salamanca, Hospital Clínic Universitari de València, l'Hospital Ramon Cajal, l'ICO Badalona i el Complex Hospitalari de Navarra, en les comunicacions següents:
- Haploidentical transplantation (HAPLO-HSCT) with busulfan based Reduced Intensity Conditioning (RIC) regimens and Post-Transplant Cyclophosphamide (PTCy) as GvHD prophylaxis in patients with relapsed/refractory Hodgkin Lymphoma (HL): Spanish Experience.
- Myeloablative Haploidentical Stem Cell Transplantation (MAC-HAPLO) With Post-Transplant Cyclophosphamide (PTCy) As Gvhd Prophylaxis In High Risk Leukemias/Myelosdisplastic Syndromes (MDS).
Antònia Sampol, hematòloga de l'Hospital Universitari Son Espases, ha participat en les comunicacions següents:
- Haploidentical Stem Cell Transplantation (HAPLO-HSCT) With Post-Transplant Cyclophosphamide (PTCy) As GVHD Prophylaxis In High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Results""Haploidentical Stem Cell Transplantation (HAPLO-HSCT) With Post-Transplant Cyclophosphamide (PTCy) As GVHD Prophylaxis In High Risk Hematologic Malignancies: Bone Marrow or Peripheral Blood Progenitors Render Same Results, junt amb l'Hospital General Universitari Gregorio Marañón, l'Hospital Regional Universitari de Màlaga, l'Hospital General Universitari Morales Meseguer, el Complex Assistencial de Salamanca, l'Hospital Clínic Universitari de València, l'Hospital Ramon Cajal, l'ICO Badalona i el Complex Hospitalari de Navarra.
- Feasibility and Efficacy of ASCT for Relapsed/Refractory Hodgkin Lymphoma in Adults Beyond 50 Years of Age: Results from the Hodgkin Lymphoma Subcommittee of the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)Feasibility and Efficacy of ASCT for Relapsed/Refractory Hodgkin Lymphoma in Adults Beyond 50 Years of Age: Results from the Hodgkin Lymphoma Subcommittee of the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO), Junt amb l'Hospital Universitari Germans Trias i Pujol, l'Hospital Universitari Marquès de Valdecilla, l'Hospital General Universitari Gregorio Marañón, l'Hospital Ramon Cajal, l'Hospital Universitari Virgen del Rocío, l'Hospital General Universitari Morales Meseguer, l'Hospital Universitari de Canarias, l'Hospital Puerta Hierro, l'Hospital Clínic Universitari Virgen de la Arrixaca i l'Hospital Universitari Sanchinarro.
- UGT2B17 minor histocompatibility mismatch and clinical outcome after hla-identical sibling donor stem cell transplantation.UGT2B17 minor histocompatibility mismatch and clinical outcome after hla-identical sibling donor stem cell transplantation, junt amb l'Hospital Universitari Dr. Josep Trueta, l'IdibGi, l'Hospital Universitari Central d'Asturies, l'Hospital General Universitari Gregorio Marañón, l'Hospital General Universitari Morales Meseguer, l'Hospital Regional Universitari de Màlaga, l'Hospital de la Santa Creu i Sant Pau, l'Hospital Ramon Cajal, l'ICO Badalona, el Complex Assistencial de Salamanca i l'Hospital Clinic de Barcelona.
Referència de l'article
41st Annual Meeting of the European Society for Blood and Marrow Transplantation 22–25 March 2015, Istanbul, Turkey. - Bone marrow transplantation (50)Text complet | Enllaços Bibliosalut
[Font: Bibliosalut]
[Foto: Fundació Banc de Sang i Teixits de les Illes Balears]
